Education
About Us
Working with TipRanks
Follow Us
Immuron Ltd (IMRN)
NASDAQ:IMRN
IMRN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.70 - $3.14
Previous CloseN/A
Volume5.19K
Average Volume (3M)4.03K
Market Cap
$11.72M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$15.21M
Total Debt (Recent Filing)AU$169.93K
Price to Earnings (P/E)―
Beta0.10
Next Earnings
Aug 29, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.85
Shares Outstanding5,838,172
10 Day Avg. Volume2,759
30 Day Avg. Volume4,025
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IMRN FAQ
What was Immuron Ltd’s price range in the past 12 months?
Immuron Ltd lowest stock price was $1.70 and its highest was $3.14 in the past 12 months.
What is Immuron Ltd’s market cap?
Immuron Ltd’s market cap is $11.72M.
When is Immuron Ltd’s upcoming earnings report date?
Immuron Ltd’s upcoming earnings report date is Aug 29, 2025 which is in 171 days.
How were Immuron Ltd’s earnings last quarter?
Immuron Ltd released its earnings results on Feb 26, 2025. The company reported -$0.272 earnings per share for the quarter, missing the consensus estimate of -$0.013 by -$0.259.
Is Immuron Ltd overvalued?
According to Wall Street analysts Immuron Ltd’s price is currently Overvalued.
Does Immuron Ltd pay dividends?
Immuron Ltd does not currently pay dividends.
What is Immuron Ltd’s EPS estimate?
Immuron Ltd’s EPS estimate is -0.01.
How many shares outstanding does Immuron Ltd have?
Immuron Ltd has 5,838,172 shares outstanding.
What happened to Immuron Ltd’s price movement after its last earnings report?
Immuron Ltd reported an EPS of -$0.272 in its last earnings report, missing expectations of -$0.013. Following the earnings report the stock price went down -1.01%.
Which hedge fund is a major shareholder of Immuron Ltd?
Currently, no hedge funds are holding shares in IMRN
---
Company Description
Immuron Ltd
Immuron Limited (IMRN) is a publicly-traded biopharmaceutical company focused on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases. The company's core products are based on its proprietary technology platform that uses polyclonal antibodies targeting specific pathogens and toxins. Immuron's flagship product, Travelan, is designed to reduce the risk of travelers' diarrhea, while its research and development pipeline includes treatments for conditions such as non-alcoholic steatohepatitis (NASH) and clostridium difficile infections.
---
IMRN Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering IMRN
1 Year
Unknown AnalystLitchfield Hills
Not Ranked
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
initiated a buy rating 6 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
---